Advances in Clinical and Experimental Medicine

Advances in Clinical and Experimental Medicine Advances in Clinical and Experimental Medicine (JCR impact factor = 2.1) is a peer-reviewed open a

        New call for submissions Innovations in Therapeutic Interventions: Advancing Clinical and Experimental MedicineH...
14/01/2025


New call for submissions

Innovations in Therapeutic Interventions: Advancing Clinical and Experimental Medicine

Handling Editors
Dr. Masaru Tanaka (ELKH-SZTE Neuroscience Research Group, Eötvös Loránd Research Network, University of Szeged (ELKH-SZTE), Hungary)
Dr. Simone Battaglia (Center for Studies and Research in Cognitive Neuroscience, Department of Psychology, University of Bologna, Italy
Dr. Francesco Di Gregorio (AUSL Bologna; Department of Psychology, University of Bologna, Italy)
Prof. Izabella Uchmanowicz (Wroclaw Medical University, Poland)
Prof. Donata Kurpas (Wroclaw Medical University, Poland)

Advances in Clinical and Experimental Medicine (Adv Clin Exp Med; IF 2.1, Scopus CiteScore 3.4) cordially invites you to contribute your valuable research to our esteemed journal. We are dedicated to promoting groundbreaking advancements in clinical and experimental medicine, focusing on emerging therapeutic strategies. We aim to enhance our impact factor and facilitate collaborations that drive progress in medicine.

We welcome reviews as well as original research articles and research letters in various clinical and experimental medicine areas. We encourage submissions on the following topics:

Precision Medicine and Personalized Therapies: Explore novel approaches in tailoring medical treatments based on an individual's genetic makeup, environmental factors, and disease characteristics. Highlight the potential of precision medicine in improving patient outcomes and overcoming treatment challenges. This topic includes but is not limited to:

a) Immunotherapy and Immunomodulation: Investigate the role of immunotherapy and immunomodulation in treating various diseases, including cancer, autoimmune disorders, and infectious diseases. Focus on cutting-edge techniques, therapeutic targets and potential synergies with other treatment modalities.
b) Gene and Cell Therapies: Present innovative research on gene and cell-based therapies, such as stem cell transplantation, gene editing and regenerative medicine. Explore their applications across different diseases and discuss their clinical implications and prospects.

The paper can also encompass:
Artificial Intelligence and Big Data Analytics in Medicine: Examine the integration of artificial intelligence (AI) and big data analytics in medical research, diagnostics, treatment optimization, and patient care. Highlight the potential of AI algorithms, machine learning and data-driven approaches in revolutionizing healthcare practices.
Digital Health Technologies and Wearables: Discuss the advancements in digital health technologies (including telemedicine), wearable devices and remote monitoring systems. Explore their impact on healthcare delivery, patient engagement, disease management, and prevention strategies.

All papers should focus on:
Translational Research and Bench-to-Bedside Innovations: Showcase translational research efforts that bridge the gap between laboratory discoveries and clinical applications. Present successful examples of bench-to-bedside innovations that have improved patient care and outcomes.

Keywords
therapeutic interventions; personalized therapies; immunotherapy; immunomodulation; gene and cell therapies; artificial intelligence; Big Data analytics; digital health technologies

By submitting your research to Adv Clin Exp Med, you will become an integral part of a dynamic and vibrant community of dedicated researchers committed to advancing the fields of clinical and experimental medicine. By undergoing our rigorous peer-review process, you can be assured that only high-quality and impactful studies are published, enhancing your professional reputation and contributing to advancing medical knowledge.

We look forward to receiving your submissions and collaborating to make a lasting impact on the field of clinical and experimental medicine.

Submission process
As a first step, we ask for submissions of an Expression of Interest with an Abstract of original papers outlining the themes above to Adv Clin Exp Med Managing Editor Marek Misiak: [email protected]
The Editor-in-Chief will review all submissions and select those invited to submit a full paper. The submission process will follow the regular Adv Clin Exp Med online process. All manuscripts will be sent to at least two independent reviewers.

Dates and fees
Submission of Expression of Interest until April 30, 2024, to the ACEM Managing Editor: [email protected];

Invitation to submit the full paper by May 31, 2024;

Submission of full paper by September 30, 2024.

If accepted, Authors will be required to pay a fee to cover publication costs (https://advances.umw.edu.pl/en/article-processing-charges/). For selected Authors (outstanding experts), reducing or even cancelling the publication fee is possible.

We look forward to a wide variety and genuinely global collection of papers and experiences to push worldwide science to the next level!

Ahead of printStudy on the role of postoperative rehabilitation based on the ERAS concept for patients undergoing pancre...
13/01/2025

Ahead of print

Study on the role of postoperative rehabilitation based on the ERAS concept for patients undergoing pancreaticoduodenectomy: Protocol for a randomized controlled clinical trial

Pancreaticoduodenectomy (PD), an abdominal surgery, is known for its complexity, cost and inherent risks. Recently, there has been increasing interest in enhanced recovery after surgery (ERAS) as a therapeutic approach. However, the mechanisms underlying postoperative functional recovery remain uncertain, and there are limited data on the efficacy of ERAS in postoperative physiotherapy following complex PD.
This study aims to examine the feasibility and effectiveness of conducting a large powered randomized controlled trial (RCT) to evaluate a 2-week postoperative rehabilitation program based on the ERAS concept for patients undergoing pancreaticoduodenectomy.

https://advances.umw.edu.pl/en/ahead-of-print/189583/

You do the research – we take care of the textAuthors of papers accepted for publication may choose special services fro...
12/01/2025

You do the research – we take care of the text

Authors of papers accepted for publication may choose special services from our experienced editorial team. The offer concerns only paper submitted for publication after March 1, 2024.

There are additional fees for the following optional services (if ordered by the Authors of the manuscript accepted for publication):

200 EUR / 880 PLN for linguistic editing;
200 EUR / 880 PLN for technical editing.
Services offered
Linguistic editing ensures that the English language of your manuscript is of the academic standard required for publication in our journal. It comprises correcting grammar, punctuation and spelling errors, pointing to inconsistencies, as well as removing or reformulating awkward or ambiguous sentences, while keeping, where possible, your voice and choice of words. We also suggest discipline-specific terms. In the proof sent to you, all our comments and doubts are clearly marked, so that you could make the necessary corrections.

Technical editing ensures that the structure of your manuscript follows the Adv Clin Exp Med house style. We reformat references (both in the text and the whole reference list) and look for missing information in the reference section. We improve the overall presentation by revising titles/subtitles, font, spacing, text alignment, and paragraph structure. We also edit equations and tables, and produce publication-ready figures that clearly communicate your research to readers. Figure editing enhances your charts and graphs, as well as graphical abstracts; it comprises revising the text included, colors, shading, border, size, resolution, and file type.

You can choose either or both of the abovementioned optional services, or decline them. When submitting the manuscript to Adv Clin Exp Med via the Editorial System, you will be provided with special checkboxes to select if needed. Following the acceptance of your article for publication, you will be asked to pay the basic APC and the additional fees for the chosen editing services.

Please be informed that the articles finally published in Adv Clin Exp Med must comply with the high standards of the journal.

More information: Managing Editor [email protected]

NEW REQUIREMENTS CONCERNING FIGURES IN ADV CLIN EXP MEDWe implemented new requirements regarding figures – they stem fro...
11/01/2025

NEW REQUIREMENTS CONCERNING FIGURES IN ADV CLIN EXP MED

We implemented new requirements regarding figures – they stem from stipulations issued by databases and digital archives in which our journal is indexed.

We accept up to 10 figures (2 figures in Research letters). Overtly complex figures will be divided into smaller ones and the number of figures will be counted again. A single figure can have no more than 6 panels (A–F). One panel means one chart – multiple small charts cannot form one panel.

All elements of each figure must be legible when viewed on an A4 page in a PDF file in full-screen mode, without zooming. Overtly complex figures with multiple charts/graphs combined into one panel cannot fulfill this requirement. Figures of low quality cannot be published, and consequently, papers with low-quality figures will not be published, even if accepted by peer reviewers.

Figures should be placed in separate files, not pasted into the main body of the text. Name your figure files with "Fig" and the figure number, e.g., Fig.1.tiff.

References to Figures should be placed according to the sequence of citing them in the manuscript. The text should include references to all figures.

Each figure should have a concise, self-explanatory caption describing accurately what the figure depicts. Captions for the figures should be placed at the end of the main body of the text. Do not embed the legend in the figure file. When applicable, be sure that both the figure captions and the figures themselves contain corresponding labels for multiple parts. Identify all elements found in the figure in the figure caption; and use boxes, circles, etc., as coordinate points in graphs. If any magnification is used in the photographs, indicate this by using scale bars within the figures themselves. All abbreviations used in a given table/figure should be explained below it or in the caption, even if a given abbreviation has already been explained in the text.

If Authors used in the work any figures, photographs, charts, tables, etc. which are not their work, and are protected by the copyright law, they shall be obliged to provide the Publisher with a written authorization to use such materials issued by the author’s economic rights holders. Identify previously published material by giving the original source in the form of a reference citation at the end of the figure caption.

OUR NEW TECHNICAL REQUIREMENTS:

https://advances.umw.edu.pl/source/Adv%20Clin%20Exp%20Med-figures-technical%20requirements.pdf

        From Bench to Bedside: Advances in Neuroinflammation and CNS Disorder ResearchAdvances in Clinical and Experimen...
10/01/2025



From Bench to Bedside: Advances in Neuroinflammation and CNS Disorder Research

Advances in Clinical and Experimental Medicine
Adv Clin Exp Med

Call for submissions of an Expression of Interest for an Adv Clin Exp Med Special Collection on Neuroinflammation in CNS Disorders

The editors of this special collection invite submissions exploring the latest advances in clinical and experimental research on neuroinflammation in the central nervous system (CNS). Neuroinflammation is at the forefront of neuroscience, shaping our understanding of CNS disorders such as neurodegenerative disease, psychiatric disorders, and traumatic brain injuries. This collection aims to unite diverse perspectives, fostering insights into the complex cellular and molecular mechanisms driving neuroinflammatory processes. We encourage the submission of original research, meta-analyses, and comprehensive review articles that shed light on diagnostic, therapeutic, and mechanistic aspects of CNS inflammation.
We are particularly interested in manuscripts that explore the interplay between immune cells, neurons, and glia, with a focus on translational research. Contributions detailing innovative diagnostic approaches, therapeutic targets, or computational models are highly welcome. Join this effort to advance the boundaries of neuroinflammation research and contribute to groundbreaking findings that bridge laboratory and clinical neuroscience.

Topic and format
Advances in Clinical and Experimental Medicine is therefore seeking original papers for a Special Collection focused on the following themes:
• Neuroimmune Interactions in Health and Disease
• Cellular and Molecular Pathways of Neuroinflammation
• Neuroinflammation and Neurodegeneration: Cause or Consequence?
• Innovative Imaging and Biomarkers for CNS Inflammation
• Therapeutic Interventions Targeting Neuroinflammation
• Role of Microglia and Astrocytes in Neuroinflammatory Diseases

Submission process
As a first step, we ask for submissions of an Expression of Interest with an Abstract of original papers outlining the themes above to Adv Clin Exp Med Section Editor: [email protected].
The Section Editor jointly with the Editor-in-Chief will review all submissions and select those which will be invited to submit a full paper. The submission process will then follow the regular Adv Clin Exp Med online process. All manuscripts will be sent to at least two independent reviewers.

Dates and fees
• Submission of Expression of Interest until June 30, 2025, to [email protected];
• Invitation to submit full paper by August 31, 2025;
• Submission of full paper by December 31, 2025;
• If accepted, Authors will be required to pay a fee (https://advances.umw.edu.pl/en/article-processing-charges/) to cover publication costs;
• For selected Authors (outstanding experts), it is possible to reduce or even cancel the publication fee.

We eagerly anticipate a diverse and truly global collection of papers and insights, driving scientific discovery and innovation to new heights on the world stage!

        Obesity Over the Life SpanAdvances in Clinical and Experimental MedicineAdv Clin Exp MedCall for submissions of ...
09/01/2025



Obesity Over the Life Span

Advances in Clinical and Experimental Medicine
Adv Clin Exp Med

Call for submissions of an Expression of Interest for an Adv Clin Exp Med Special Collection on Obesity Over the Life Span

This Special Issue of Advances in Clinical and Experimental Medicine will provide focused, comprehensive coverage of key clinical and public health issues related to obesity. Over the last three decades, the global prevalence of obesity has more than doubled, reflecting profound shifts in lifestyle, diet, and environmental determinants of health. Obesity has become the dominant form of malnutrition worldwide, contributing to a broad spectrum of health complications, including chronic diseases, functional impairments, and reduced quality of life.
This Special Issue aims to provide researchers and clinicians with an opportunity to publish original research, meta-analyses, and review articles addressing recent advances in the epidemiology, prevention, and treatment of obesity. Emphasis will be placed on multidisciplinary approaches, personalized management strategies, and the life-course perspective of this growing epidemic.

Topic and format
Advances in Clinical and Experimental Medicine is therefore seeking original papers for a Special Collection focused on the following themes:
• Global trends and epidemiology of obesity across all age groups.
• Prevention strategies targeting childhood, adolescent, and adult obesity.
• Innovative treatment approaches: lifestyle modifications, diet therapy, physical activity, pharmacotherapy, and bariatric surgery.
• Health complications of obesity and their management.
• Impact of obesity on public health systems and clinical practice.
• Multidisciplinary interventions.

Submission process
As a first step, we ask for submissions of an Expression of Interest with an Abstract of original papers outlining the themes above to Adv Clin Exp Med Section Editor: [email protected], [email protected] and [email protected];
The Section Editor jointly with the Editor-in-Chief will review all submissions and select those which will be invited to submit a full paper. The submission process will then follow the regular Adv Clin Exp Med online process. All manuscripts will be sent to at least two independent reviewers.

Dates and fees
• Submission of Expression of Interest until June 30, 2025, to [email protected], [email protected] and [email protected];
• Invitation to submit full paper by August 31, 2025;
• Submission of full paper by December 31, 2025;
• If accepted, Authors will be required to pay a fee (https://advances.umw.edu.pl/en/article-processing-charges/) to cover publication costs;
• For selected Authors (outstanding experts), it is possible to reduce or even cancel the publication fee.

We are looking forward to a wide variety and truly global collection of papers and experiences to push worldwide science to the next level!

        Ahead of printDevelopment and validation of the antibody-dependent cellular phagocytosis-based signature: A prog...
08/01/2025



Ahead of print

Development and validation of the antibody-dependent cellular phagocytosis-based signature: A prognostic risk model of gastric cancer

Accumulating evidence has supported the effect of antibody-dependent cellular phagocytosis (ADCP) on the tumor microenvironment (TME) and cancer therapy. However, an ADCP-based signature to predict the prognosis of gastric cancer (GC) has not been established. The authors aimed to develop an ADCP-based signature to improve the prognosis prediction of GC.

https://advances.umw.edu.pl/en/ahead-of-print/189914/

        Ahead of printLaboratory synthesis and preparation of thermo-responsive polymeric micelle and hydrogel for resve...
07/01/2025



Ahead of print

Laboratory synthesis and preparation of thermo-responsive polymeric micelle and hydrogel for resveratrol delivery and release

Resveratrol (RSV) exhibits anti-inflammatory, antioxidative, antiaging, and cardioprotective properties. However, due to its hydrophobic nature, it is prone to instability and oxidation, which significantly limit its biomedical applications.
The aims of this study were: 1) To prepare and characterize hydrogels and micelles by mixing the synthesized PNIPAM-b-PEO-b-PNIPAM copolymer and RSV in an aqueous environment; 2) To investigate the molecular interactions between the polymer and RSV; 3) To evaluate various properties of the polymeric micelles and hydrogels; 4) To determine the efficiency of RSV release from the polymeric micelles.

https://advances.umw.edu.pl/en/ahead-of-print/190546/

        Ahead of printMicrobial metabolomics in acute myeloid leukemia: From pathogenesis to treatmentAcute myeloid leuk...
06/01/2025



Ahead of print

Microbial metabolomics in acute myeloid leukemia: From pathogenesis to treatment

Acute myeloid leukemia (AML), the most common leukemia in adults, is a biologically heterogeneous disease arising from clonally proliferating hematopoietic stem cells. Increased appreciation of novel genetic methods has improved the understanding of AML biology. Recently, the emerging field of metabolomics has indicated qualitative and quantitative alterations in metabolic profiles in AML pathogenesis, progression and treatment. Multiple metabolic and molecular pathways regulate human metabolism and host–microbiome interactions may significantly affect this biochemical machinery. Microbiota have been found to play a significant role in hematopoietic function, metabolism and immunity, contributing to AML occurrence. A large number of studies have highlighted the importance of the composition and diversity of the gut microbiota (GM) in response to treatment and prognosis in AML. Moreover, strong evidence emphasizes the detrimental link between dysbiosis and infectious complications, a leading cause of morbidity and mortality for patients with AML. Several microbiota-related mechanisms have been linked to particular changes in host physiology so far, and microbial-derived metabolites belong to one of the most important. Circulating in the body, they modulate human conditions both locally and systemically. The extensive and diverse repertoire of bacterial metabolic functions plays a critical role in numerous processes, including leukemogenesis. Integrative analysis of microbiome and metabolome data is a promising avenue for better understanding the complex relationship between the microbiota, biochemical alterations and AML pathogenesis to effectively prevent, treat and mitigate its outcomes. This review concentrates on the pathologic roles and therapeutic implications of microbe-derived metabolites in AML settings.

https://advances.umw.edu.pl/en/ahead-of-print/191559/

If you experience problems in choosing a checklist, use this :-)To improve the success rate of publishing articles, auth...
05/01/2025

If you experience problems in choosing a checklist, use this :-)

To improve the success rate of publishing articles, authors can consider these checklists which will be considered as a checklist by the Reviewers in the review process.

Using a checklist can help you get published faster and maximize the impact of your work. The below checklists are copied from a tool was made by the EQUATOR Network in collaboration with Penelope.ai.

https://humangeneticsgenomics.ir/page/169/Checklists

New statistical guidelinesEditors of Adv Clin Exp Med are well aware that correct analysis of statistical data and repor...
04/01/2025

New statistical guidelines

Editors of Adv Clin Exp Med are well aware that correct analysis of statistical data and reporting the results of such analysis is not easy even for experienced researchers – because we are dealing with really, not only ostensibly complicated matters. Specialists from the Centre for Statistical Analysis at the Wroclaw Medical University want to provide you as much help as guidance as possible – and prepared these detailed guidelines for all authors wishing to submit their manuscripts to our journal.

https://advances.umw.edu.pl/source/ACEM%20Statistical%20guidelines%202024%20%E2%80%94%20New.pdf

Life it is not just a series of calculations and a sum total of statistics, it's about experience, it's about participation, it is something more complex and more interesting than what is obvious

[Daniel Libeskind, American architect and thinker]

CITE US!When you publish your paper in our journal, you certainly hope it will be cited frequently. The higher the impac...
03/01/2025

CITE US!

When you publish your paper in our journal, you certainly hope it will be cited frequently. The higher the impact factor a given journal has, the higher are also the chances that its content would be cited. This in turn boosts the impact factor of the journal – and a virtuous circle begins.

If you choose to publish an article in another journal with an impact factor higher than that of Advances in Clinical and Experimental Medicine (2.1), we kindly request that you consider citing papers published in our journal from the years 2022–2023 if your article will be published in 2024, and papers from 2023–2024 if your article will be published in 2025.

https://advances.umw.edu.pl/en/when-you-cite-us

        Ahead of printPrognostic value of inflammation-related model in hepatitis B acute-on-chronic liver failureAcute-...
03/01/2025



Ahead of print

Prognostic value of inflammation-related model in hepatitis B acute-on-chronic liver failure

Acute-on-chronic liver failure (ACLF) is characterized by rapid onset, rapid development and a high short-term mortality rate. Systemic inflammation exerts an effect on the disease progression of ACLF.
The purposes of this study were to explore the clinical significance that the inflammatory response has on the disease process of hepatitis B virus acute-on-chronic liver failure (HBV-ACLF) patients, to further compare the values of different inflammation-related biomarkers in the prognosis evaluation of HBV-ACLF patients, and to combine inflammatory-related markers to establish a new prediction model.

https://advances.umw.edu.pl/en/ahead-of-print/192624/

Publish in Advances in Clinical and Experimental Medicine!WHY?– We have a broad scope and publish papers from all fields...
02/01/2025

Publish in Advances in Clinical and Experimental Medicine!

WHY?

– We have a broad scope and publish papers from all fields of medicine and related sciences;
– Our Impact Factor is 2.1 and steadily rising [see below];
– Our Scopus CiteScore is 3.7 and also steadily rising;
– We publish papers ahead of print [with active DOI] as soon as they are ready – no unnecessary waiting;
– We are indexed in all important databases;
– We offer professional linguistic editing and DTP;
– If you become our reviewer, article processing charge can be waivered.

HOW?
Create an account here:

https://www.editorialsystem.com/acem/preRegister/?email=

Check our instructions for authors here:

https://advances.umw.edu.pl/en/instructions-for-authors/
and submit your paper!

EDITORIALS
We invite experts to submit an editorial to our journal. Editorials published in our journal are meant to promote current and crucial directions of research in experimental and clinical medicine. Such article is published free of charge.

https://advances.umw.edu.pl/.../Editorials-popr_IF%20(1).pdf

CALLS FOR SUBMISSION
Current calls for submissions in ACEM are listed below. Please share them with the members of your professional networks.

https://advances.umw.edu.pl/en/calls-for-submissions/

OUR IMPACT FACTOR
There has been a rise in the impact factor value for ACEM since 2018. A constant rise in this value shows that the position of ACEM among medical journals is gradually increasing. The current value of impact factor 2021 is 2.1. The approximate value of impact factor 2022 is 2.020.

WEB OF SCIENCE CORE COLLECTION
Since 2007, a total of 2297 papers published in ACEM were indexed in databases of Web of Science. These articles were cited 14,682 times. Currently, the average citation per item is 6.39. Last year, the average citation per item was 5.09. This score shows an increased probability of being cited when publishing an article in our journal.

        Ahead of printResearch status and controversy on non-small cell lung cancer stem cellsLung cancer is a major cau...
02/01/2025



Ahead of print

Research status and controversy on non-small cell lung cancer stem cells

Lung cancer is a major cause of cancer-related deaths worldwide. It can be divided into 2 main types, namely non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Most patients with NSCLC are diagnosed at an advanced stage, and current treatments have limited success. Moreover, relapsing tumors that often appear after surgical or drug treatment are particularly difficult to treat. The existence of cancer stem cells (CSCs) has been proposed as a key factor contributing to the development of resistance to therapy, recurrence and metastasis. Targeting CSCs is a potential strategy for eradicating tumors. However, due to the tumor-type specificity and cellular plasticity, the real clinical application of lung cancer stem cells (LCSCs) has not been realized. This review details the existing phenotypic markers of LCSCs and the limitations of their identification and summarizes the roles of the tumor microenvironment (TME) and epithelial–mesenchymal transition (EMT) in the existence and maintenance of LCSCs, as well as the contribution and controversy of cellular plasticity theory on LCSCs. It is expected that future research on LCSCs can solve the present problems, and approaches targeting LCSCs may be applied in the clinic as soon as possible.

https://advances.umw.edu.pl/en/ahead-of-print/187053/

Carol Ann DuffyNew YearI drop the dying year behind me like a shawland let it fall. The urgent fireworks fling themselve...
01/01/2025

Carol Ann Duffy
New Year

I drop the dying year behind me like a shawl
and let it fall. The urgent fireworks fling themselves
against the night, flowers of desire, love’s fervency.
Out of the space around me, standing here, I shape
your absent body against mine. You touch me as the giving air.

Most far, most near, your arms are darkness, holding me,
so I lean back, lip-read the heavens talking on in light,
syllabic stars. I see, at last, they pray at us. Your breath
is midnight’s, living, on my skin, across the miles between us,
fields and motorways and towns, the million lit-up little homes.

This love we have, grief in reverse, full rhyme, wrong place,
wrong time, sweet work for hands, the heart’s vocation, flares
to guide the new year in, the days and nights far out upon the sky’s
dark sea. Your mouth is snow now on my lips, cool, intimate, first kiss,
a vow. Time falls and falls through endless space, to when we are.

[Source: Carol Ann Duffy, “Selected Poems”, London, UK: Penguin Press; 1994]

Brian Bilston[This was the year that was not the year…]This was the year that was not the yearI repaired the bathroom ta...
31/12/2024

Brian Bilston
[This was the year that was not the year…]

This was the year that was not the year
I repaired the bathroom tap
and emptied out the kitchen drawer
of a lifetime’s worth of crap.

This was the year that was not the year
in which I launched a new career.
516 A West End hit eluded me
as did Time Person of the Year.

This was the year that was not the year
I became a household name.
Action figures were not sold of me.
I wasn’t made a dame.

This was the year that was not the year
I spent less time on my phone.
Nights of passion did not happen
in boutique hotels in Rome.

This was the year that was the year
I didn’t get that much done –
much the same as the year before,
much like the one to come.

[Source: Brian Bilson, “Days Like These: An Alternative Guide to the Year in 366 Poems”, London, UK: Picador; 2022]

        Ahead of printEffect of reduced saturation and elevated D-dimer and interleukin 6 levels on vessel density and f...
30/12/2024



Ahead of print

Effect of reduced saturation and elevated D-dimer and interleukin 6 levels on vessel density and foveal avascular zone in patients with COVID-19 bilateral pneumonia

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can affect multiple organs, including the eyes.
This study aimed to identify associations between vascular density (VD) and the foveal avascular zone (FAZ), assessed using optical coherence tomography angiography (OCTA), and baseline levels of D-dimers and interleukin 6 (IL-6) in patients with bilateral COVID-19 pneumonia, depending on oxygen saturation (SpO2) on admission.

https://advances.umw.edu.pl/en/ahead-of-print/191774/

Adres

Karola Marcinkowskiego 2-6
Wroclaw
50-368

Godziny Otwarcia

Poniedziałek 08:00 - 16:00
Wtorek 08:00 - 16:00
Środa 08:00 - 16:00
Czwartek 08:00 - 16:00
Piątek 08:00 - 16:00

Telefon

+48607983232

Ostrzeżenia

Bądź na bieżąco i daj nam wysłać e-mail, gdy Advances in Clinical and Experimental Medicine umieści wiadomości i promocje. Twój adres e-mail nie zostanie wykorzystany do żadnego innego celu i możesz zrezygnować z subskrypcji w dowolnym momencie.

Skontaktuj Się Z Firmę

Wyślij wiadomość do Advances in Clinical and Experimental Medicine:

Udostępnij

Kategoria